MedTrace Logo

A Clinical Study of the TSX Dental Implant System (Xpresso)

NCT06571812 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 62

Last updated 2026-05-06

No results posted yet for this study

Summary

A prospective, observational, multicenter study where 62 patients needing implants in the maxilla or mandible will be enrolled. The patients will be restored with a final prosthesis no later than 4 months following implant placement surgery. The patients will come back for follow-up evaluations yearly for 2 years.

Conditions

  • Tooth Loss

Interventions

DEVICE

TSX

Treatment of tooth loss with TSX dental implants

Sponsors & Collaborators

  • ZimVie

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-24
Primary Completion
2027-12-30
Completion
2028-04-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06571812 on ClinicalTrials.gov